Educational intervention for metabolic bone disease in patients with chronic kidney disease: A systematic review and meta-analysis

Journal of Renal Nutrition

Volumn 24, Issue 6, 2014, Pages 371-384

  Shi, Yuexian ^a,b   Zhao, Yinning ^c   Liu, Junduo ^d   Hou, Yahong ^b   Zhao, Yue ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^c The First People's Hospital of Yinchuan   (China)

^d TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; PHOSPHORUS;

ATTITUDE TO HEALTH; BLOOD; BONE DISEASES, METABOLIC; COMPLICATION; FACTUAL DATABASE; HUMAN; HYPERPHOSPHATEMIA; META ANALYSIS; PATHOLOGY; PATIENT EDUCATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

BIOMARKERS; BONE DISEASES, METABOLIC; CALCIUM; DATABASES, FACTUAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERPHOSPHATEMIA; PATIENT EDUCATION AS TOPIC; PHOSPHORUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84908405716     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2014.06.007     Document Type: Review

References (49)

1. Hoerger T.J., Wittenborn J.S., Zhuo X., et al. Cost-effectiveness of screening for microalbuminuria among African Americans. J Am Soc Nephrol 2012, 23:2035-2041.
2. Allen A.S., Forman J.P., Orav E.J., et al. Primary care management of chronic kidney disease. J Gen Intern Med 2011, 26:386-392.
3. Couser W.G., Remuzzi G., Mendis S., et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011, 80:1258-1270.
4. Joki N., Tanaka Y. CKD-MBD (chronic kidney disease-mineral and bone disorder). Atheroma and vascular calcification in hemodialysis patients. Clin Calcium 2010, 20:1061-1066.
5. Lewis R. Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management. Ann Clin Biochem 2012, 49(Pt 5):432-444.
6. Uhlig K., Berns J.S., Kestenbaum B., et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 2010, 55:773-799.
7. Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009, 113:S1-S130.
8. Wesseling-Perry K., Salusky I.B. Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children. Pediatr Nephrol 2013, 28:617-625.
9. Chartsrisak K., Vipattawat K., Assanatham M., et al. Mineral metabolism and outcomes in chronic kidney disease stage 2-4 patients. BMC Nephrol 2013, 16:1-14.
10. Martin K.J., Gonzalez E.A. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol 2007, 18:875-885.
11. Di Angelantonio E., Chowdhury R., Sarwar N., et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010, 341:1-7.
12. Hruska K.A., Choi E.T., Memon I., et al. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr Nephrol 2010, 25:769-778.
13. Cozzolino M. Prevention and treatment of CKD-MBD. Nephrourol Mon 2013, 5:773-774.
14. Williams A., Manias E., Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 2008, 63:132-143.
15. Jamal S.A., Vandermeer B., Raggi P., et al. Effect of calcium based versus non calcium based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 2013, 382:1268-1277.
16. Duranton F., Rodriguez-Ortiz M.E., Duny Y., et al. Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol 2013, 37:239-248.
17. Caldeira D., Amaral T., David C., et al. Educational strategies toreduceserum phosphorus in hyperphosphatemic patients with chronic kidney disease: systematic review with meta-analysis. J Ren Nutr 2011, 21:285-294.
18. Sun C.Y., Chang K.C., Chen S.H., et al. Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. Ren Fail 2008, 30:57-62.
19. Reddy V., Symes F., Sethi N., et al. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population. J Ren Nutr 2009, 19:314-320.
20. Morey B., Walker R., Davenport A. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract 2008, 109:173-180.
21. Cochrane handbook for systematic reviews of interventions, version 5.0.2 2008, The Cochrane Collaboration and John Wiley & Sons, Chichester, West Sussex. J.P.T. Higgins, S. Green (Eds.).
22. Shaw-Stuart N.J., Stuart A. The effect of an educational patient compliance program on serum phosphate levels in patients receiving hemodialysis. J Ren Nutr 2000, 10:80-84.
23. Dashti-Khavidaki S., Khalili H., Shahverdi S., et al. The role of clinical pharmacy services in achieving treatment targets in Iranian haemodialysis patients. Singapore Med J 2012, 53:599-603.
24. Mayne T.J., Benner D., Ricketts K., et al. Results of a pilot program to improve phosphorus outcomes in hemodialysis patients. J Ren Nutr 2012, 22:472-479.
25. Schlatter S., Ferrans C.E. Teaching program effects on high phosphoruslevels in patients receiving hemodialysis. ANNA J 1998, 25:31-36.
26. Chen Y.R., Yang Y., Wang S.C., et al. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study. Nephrol Dial Transplant 2013, 28:671-682.
27. Drawz P.E., Miller R.T., Singh S., Watts B., Kern E. Impact of a chronickidney disease registry and provider education on guideline adherence a cluster randomized controlled trial. BMC Med Inform Decis Mak 2012, 12:1-8.
28. Baraz S., Parvardeh S., Mohammadi E., et al. Dietary and fluid compliance: an educational intervention for patients having haemodialysis. JAdv Nurs 2010, 66:60-68.
29. Van Zuilen A.D., Bots M.L., Dulger A., et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int 2012, 82:710-717.
30. Van Zuilen A.D., Wetzels J.F., Bots M.L., et al. MASTERPLAN: study ofthe role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol 2008, 21:261-267.
31. Griva K., Mooppil N., Seet P., et al. The NKF-NUS hemodialysis trial protocol-a randomized controlled trial to determine the effectiveness of a selfmanagement intervention for hemodialysis patients. BMC Nephrol 2011, 12:1-11.
32. Van Camp Y.P., Huybrechts S.A., Van Rompaey B., et al. Nurse-led education and counseling to enhance adherence to phosphate binders. JClin Nurs 2012, 21:1304-1313.
33. Foley S. Nutrition counseling to lower serum phosphorus levels. Accessed July 24, 2014. http://www.controlled-trials.com/mrct/trial/424195/NCT00296439.
34. Degen JA. Intensive dietary education using the phosphorus point system tool to improve hyperphosphatemia in patients with chronic kidney disease. Accessed date July 24, 2014. http://hdl.handle.net/1807/18272.
35. Ashurst Ide B., Dobbie H. A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients. J Ren Nutr 2003, 13:267-274.
36. Ford J.C., Pope J.F., Hunt A.E., et al. The effect of diet education on thelaboratory values and knowledge of hemodialysis patients with hyperphosphatemia. J Ren Nutr 2004, 14:36-44.
37. Karamanidou C., Weinman J., Horne R. Improving haemodialysis patients understanding of phosphate-binding medication: a pilot study of a psycho-educational intervention designed to change patients' perceptions of the problem and treatment. Br J Health Psychol 2008, 13(Pt 2):205-214.
38. Yokum D., Glass G., Cheung C.F., et al. Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients. J Ren Nutr 2008, 18:521-529.
39. Sullivan C., Sayre S.S., Leon J.B., et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009, 301:629-635.
40. Karavetian M., Ghaddar S. Nutritional education for the management of osteodystrophy (nemo) in patients on haemodialysis: a randomised controlled trial. J Ren Care 2013, 39:19-30.
41. Forni Ogna V., Pruijm M., Zweiacker C., et al. Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study. Biomed Res Int 2013, 2013:1-7.
42. Shi Y.X., Fan X.Y., Han H.J., et al. Effectiveness of a nurse-led intensive educational programme on chronic kidney failure patients with hyperphosphataemia: randomized controlled trial. J Clin Nurs 2013, 22:1189-1197.
43. Mellon L., Regan D., Curtis R. Factors influencing adherence among Irish haemodialysis patients. Patient Educ Couns 2013, 92:88-93.
44. Matteson M.L., Russell C. Interventions to improve hemodialysis adherence: a systematic review of randomized-controlled trials. Hemodial Int 2010, 14:370-382.
45. Hung K.Y., Liao S.C., Chen T.H., et al. Adherence to phosphate binder therapy is the primary determinant of hyperphosphatemia incidence in patients receiving peritoneal dialysis. Ther Apher Dial 2013, 17:72-77.
46. Idier L., Untas A., Koleck M., et al. Assessment and effects of Therapeutic Patient Education for patients in hemodialysis: a systematic review. Int J Nurs Stud 2011, 48:1570-1586.
47. Gutiérrez O.M., Anderson C., Isakova T., et al. Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 2010, 21:1953-1960.
48. Kuhlmann M.K. Management of hyperphosphatemia. Hemodial Int 2006, 10:338-345.
49. Sherman R.A., Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 2009, 54:18-23.